Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Edetate disodium MedWatch alert

Executive Summary

FDA advising hospitals to evaluate need to keep Edetate Disodium stocked and consider removing it from shelves to avoid confusion with similarly named Edetate Calcium Disodium. Edetate Disodium is approved to treat patients with hypercalcemia or digitalis in the blood while Edetate Calcium Disodium is approved to treat severe lead poisoning, but both products are used off-label as chelators and use the same abbreviation. The agency issues a public health advisory for Hospira's Endrate and generics Jan. 18 because of several fatalities caused by confusion of the drug names...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS049203

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel